- Home
- WIA vs PROF Comparison
WIA vs PROF Comparison
Compare WIA & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- PROF
- Stock Information
- Founded
- WIA 2003
- PROF N/A
- Country
- WIA United States
- PROF Canada
- Employees
- WIA N/A
- PROF N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- PROF Medical/Dental Instruments
- Sector
- WIA Finance
- PROF Health Care
- Exchange
- WIA Nasdaq
- PROF Nasdaq
- Market Cap
- WIA 191.5M
- PROF 186.3M
- IPO Year
- WIA N/A
- PROF N/A
- Fundamental
- Price
- WIA $8.06
- PROF $7.24
- Analyst Decision
- WIA
- PROF Strong Buy
- Analyst Count
- WIA 0
- PROF 2
- Target Price
- WIA N/A
- PROF $11.40
- AVG Volume (30 Days)
- WIA 39.2K
- PROF 106.8K
- Earning Date
- WIA 01-01-0001
- PROF 11-07-2024
- Dividend Yield
- WIA 12.29%
- PROF N/A
- EPS Growth
- WIA N/A
- PROF N/A
- EPS
- WIA N/A
- PROF N/A
- Revenue
- WIA N/A
- PROF $8,984,000.00
- Revenue This Year
- WIA N/A
- PROF $56.61
- Revenue Next Year
- WIA N/A
- PROF $160.87
- P/E Ratio
- WIA N/A
- PROF N/A
- Revenue Growth
- WIA N/A
- PROF 39.35
- 52 Week Low
- WIA $7.56
- PROF $6.88
- 52 Week High
- WIA $8.91
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- WIA 27.42
- PROF 40.10
- Support Level
- WIA $8.09
- PROF $7.00
- Resistance Level
- WIA $8.31
- PROF $7.40
- Average True Range (ATR)
- WIA 0.08
- PROF 0.40
- MACD
- WIA -0.02
- PROF -0.07
- Stochastic Oscillator
- WIA 11.43
- PROF 15.52
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.